GEN Exclusives

More »

GEN News Highlights

More »
Sep 13, 2007

SRI and Pentax to Advance Diagnostic Tool Development for Cancer

  • SRI International initiated a personalized medicine program to find cancer biomarkers to make diagnostic tools. This project is part of a multiyear collaboration with Pentax.

    Pentax will provide research funding and R&D milestone payments to SRI as well as royalties on sales of any resulting products.

    “Pentax and SRI are jointly addressing new opportunities in personalized medicine by developing diagnostic tools to assist in rapid and accurate selection of therapeutic options for treatment on an individual patient basis,” remarks Akira Yamamoto, research head at the Pentax Incubation Center and program director for the Pentax–SRI partnership.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »